UK markets open in 7 hours 17 minutes

COMPASS Pathways plc (CMPS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.29+0.05 (+0.80%)
At close: 04:00PM EDT
6.25 -0.04 (-0.64%)
After hours: 07:11PM EDT

COMPASS Pathways plc

33 Broadwick Street
London W1F 0DQ
United Kingdom
44 71 6676 6461
https://compasspathways.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full-time employees186

Key executives

NameTitlePayExercisedYear born
Mr. Kabir Kumar Nath M.A., M.B.A.CEO & Director1.31MN/A1964
Mr. Matthew Allen OwensGeneral Counsel & Chief Legal Officer684.51kN/A1977
Dr. Guy GoodwinChief Medical Officer567kN/A1948
Ms. Teri Loxam M.B.A.CFO, Principal Financial Officer & Principal Accounting OfficerN/AN/A1973
Dr. Greg Ryslik Ph.D.Chief Technology OfficerN/AN/AN/A
Mr. Stephen D. SchultzSenior Vice President of Investor RelationsN/AN/AN/A
Mr. Christopher WilliamsChief Communications OfficerN/AN/AN/A
Ms. Anne BenedictChief People OfficerN/AN/AN/A
Mr. Lars Christian WildeSenior AdvisorN/AN/A1985
Mr. Trevor MillChief Development OfficerN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Corporate governance

COMPASS Pathways plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.